AHI1
Jouberin
Also known as: AHI1_HUMAN, FLJ20069, JBTS3, ORF1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N157
- Gene
- AHI1
- Ensembl
- ENSG00000135541
- Chromosome
- 6
- Canonical length
- 1196 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Primary cilium,Centrosome
OverviewNCBI Gene
This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
1196 residues, UniProt reviewed canonical sequence.
>Q8N157|AHI1
1 MPTAESEAKV KTKVRFEELL KTHSDLMREK KKLKKKLVRS EENISPDTIR SNLHYMKETT
61 SDDPDTIRSN LPHIKETTSD DVSAANTNNL KKSTRVTKNK LRNTQLATEN PNGDASVEED
121 KQGKPNKKVI KTVPQLTTQD LKPETPENKV DSTHQKTHTK PQPGVDHQKS EKANEGREET
181 DLEEDEELMQ AYQCHVTEEM AKEIKRKIRK KLKEQLTYFP SDTLFHDDKL SSEKRKKKKE
241 VPVFSKAETS TLTISGDTVE GEQKKESSVR SVSSDSHQDD EISSMEQSTE DSMQDDTKPK
301 PKKTKKKTKA VADNNEDVDG DGVHEITSRD SPVYPKCLLD DDLVLGVYIH RTDRLKSDFM
361 ISHPMVKIHV VDEHTGQYVK KDDSGRPVSS YYEKENVDYI LPIMTQPYDF KQLKSRLPEW
421 EEQIVFNENF PYLLRGSDES PKVILFFEIL DFLSVDEIKN NSEVQNQECG FRKIAWAFLK
481 LLGANGNANI NSKLRLQLYY PPTKPRSPLS VVEAFEWWSK CPRNHYPSTL YVTVRGLKVP
541 DCIKPSYRSM MALQEEKGKP VHCERHHESS SVDTEPGLEE SKEVIKWKRL PGQACRIPNK
601 HLFSLNAGER GCFCLDFSHN GRILAAACAS RDGYPIILYE IPSGRFMREL CGHLNIIYDL
661 SWSKDDHYIL TSSSDGTARI WKNEINNTNT FRVLPHPSFV YTAKFHPAVR ELVVTGCYDS
721 MIRIWKVEMR EDSAILVRQF DVHKSFINSL CFDTEGHHMY SGDCTGVIVV WNTYVKINDL
781 EHSVHHWTIN KEIKETEFKG IPISYLEIHP NGKRLLIHTK DSTLRIMDLR ILVARKFVGA
841 ANYREKIHST LTPCGTFLFA GSEDGIVYVW NPETGEQVAM YSDLPFKSPI RDISYHPFEN
901 MVAFCAFGQN EPILLYIYDF HVAQQEAEMF KRYNGTFPLP GIHQSQDALC TCPKLPHQGS
961 FQIDEFVHTE SSSTKMQLVK QRLETVTEVI RSCAAKVNKN LSFTSPPAVS SQQSKLKQSN
1021 MLTAQEILHQ FGFTQTGIIS IERKPCNHQV DTAPTVVALY DYTANRSDEL TIHRGDIIRV
1081 FFKDNEDWWY GSIGKGQEGY FPANHVASET LYQELPPEIK ERSPPLSPEE KTKIEKSPAP
1141 QKQSINKNKS QDFRLGSESM THSEMRKEQS HEDQGHIMDT RMRKNKQAGR KVTLIELocalizationUniProt · AlphaFold · HPA
Whether an antibody against AHI1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- retina: 25 nTPM
- testis: 12 nTPM
- pituitary gland: 7.8 nTPM
- parathyroid gland: 6.6 nTPM
- adrenal gland: 6 nTPM
- epididymis: 5.8 nTPM
Single-cell type
- thyrotrophs: 2,329 nCPM
- lactotrophs: 2,085 nCPM
- rod photoreceptor cells: 2,048 nCPM
- somatotrophs: 1,929 nCPM
- cone photoreceptor cells: 1,511 nCPM
- gonadotrophs: 1,278 nCPM
Immune cell
- plasmacytoid DC: 22 nTPM
- naive B-cell: 14 nTPM
- memory B-cell: 12 nTPM
- basophil: 11 nTPM
- NK-cell: 6.4 nTPM
- gdT-cell: 6 nTPM
Brain region
- hypothalamus: 59 nTPM
- cerebellum: 46 nTPM
- white matter: 45 nTPM
- cerebral cortex: 41 nTPM
- midbrain: 39 nTPM
- medulla oblongata: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AHI1.
Disease | AllUniProt
Conditions AHI1 is implicated in, by any mechanism.
- Joubert syndrome 3 (JBTS3) MIM:608629
Disease | GeneticClinVar
271 pathogenic / likely-pathogenic of 1,770 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.03
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor protein tyrosine kinase signaling pathway
- cilium assembly
- intracellular protein localization
- motile cilium assembly
- negative regulation of apoptotic process
- photoreceptor cell outer segment organization
- positive regulation of receptor internalization
- positive regulation of transcription by RNA polymerase II
- regulation of behavior
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SH3 domain
- WD40 repeat
- WD40/YVTN repeat-like-containing domain superfamily
- SH3-like domain superfamily
- WD40-repeat-containing domain superfamily
- SH3 domain
- WD domain, G-beta repeat
- Jouberin, SH3 domain
- Primary Cilium-Associated Jouberin
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AHI1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AHI1 as an antibody target. Whether an autoantibody or antibody against AHI1 could matter depends on whether native AHI1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AHI1 is annotated at the cell surface, where native AHI1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AHI1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...